<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">HPV vaccination of immunocompromised hosts</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-06-03">03 June 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Papillomavirus</forename><surname>Research</surname></persName>
						</author>
						<author>
							<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Garland</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Microbiology and Infectious Diseases</orgName>
								<orgName type="institution">Royal Women&apos;s Hospital</orgName>
								<address>
									<addrLine>30 Flemington Road</addrLine>
									<postCode>3052</postCode>
									<settlement>Parkville</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Murdoch Childrens Research Institute</orgName>
								<address>
									<addrLine>50 Flemington Road</addrLine>
									<postCode>3052</postCode>
									<settlement>Parkville</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Obstetrics and Gynaecology</orgName>
								<orgName type="institution">University of Melbourne</orgName>
								<address>
									<postCode>3052</postCode>
									<settlement>Parkville</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><forename type="middle">M L</forename><surname>Brotherton</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Victorian Cytology Service</orgName>
								<orgName type="institution">VCS Registries</orgName>
								<address>
									<addrLine>Level 6, 176 Wellington Parade</addrLine>
									<postCode>3002</postCode>
									<settlement>East Melbourne</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">School of Population and Global Health</orgName>
								<orgName type="institution">University of Melbourne</orgName>
								<address>
									<postCode>3052</postCode>
									<settlement>Parkville</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Moscicki</surname></persName>
							<email>amoscicki@mednet.ucla.edu</email>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Department of Pediatrics</orgName>
								<orgName type="department" key="dep2">David Geffen School of Medicine</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<addrLine>10833 Le Conte Ave. MDCC 22-432</addrLine>
									<postCode>175217, 90095</postCode>
									<settlement>Los Angeles, Los Angeles</settlement>
									<region>MC:, CA</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Kaufmann</surname></persName>
							<email>andreas.kaufmann@charite.de</email>
							<affiliation key="aff6">
								<orgName type="department">Gynäkologische Tumorimmunologie</orgName>
								<orgName type="institution">Charite-Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin, Hindenburgdamm 30</addrLine>
									<postCode>R. 4503, 12200</postCode>
									<settlement>Gynäkologie, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Stanley</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Pathology</orgName>
								<address>
									<addrLine>Tennis Court Road</addrLine>
									<postCode>CB2 1QP</postCode>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">N</forename><surname>Bhatla</surname></persName>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Department of Obstetrics &amp; Gynaecology</orgName>
								<orgName type="department" key="dep2">Institute of Medical Sciences</orgName>
								<address>
									<postCode>110029</postCode>
									<settlement>New Delhi</settlement>
									<country>All India, India</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><surname>Sankaranarayanan</surname></persName>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Section of Early Detection and Prevention</orgName>
								<orgName type="department" key="dep2">International Agency for Research on Cancer</orgName>
								<orgName type="laboratory">Screening Group</orgName>
								<orgName type="institution">World Health Organization</orgName>
								<address>
									<addrLine>150 cours Albert Thomas</addrLine>
									<postCode>69372, CEDEX 08</postCode>
									<settlement>Lyon</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>De Sanjosé</surname></persName>
							<affiliation key="aff10">
								<orgName type="department" key="dep1">Cancer Epidemiology Research Programme</orgName>
								<orgName type="department" key="dep2">Institut Català d&apos;Oncologia</orgName>
								<orgName type="institution" key="instit1">IDIBELL</orgName>
								<orgName type="institution" key="instit2">CIBERESP</orgName>
								<address>
									<addrLine>Av. Gran Via de l&apos;Hospitalet 199-203</addrLine>
									<postCode>08908</postCode>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="institution">L&apos;Hospitalet de Llobregat</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Palefsky</surname></persName>
							<email>joel.palefsky@ucsf.edu</email>
							<affiliation key="aff12">
								<orgName type="institution">University of California</orgName>
								<address>
									<addrLine>513 Parnassus Ave</addrLine>
									<postBox>Box 0654</postBox>
									<postCode>94143</postCode>
									<settlement>San Francisco, San Francisco</settlement>
									<region>CA</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff13">
								<orgName type="department">Department of Microbiology and Infectious Diseases</orgName>
								<orgName type="institution">Royal Women&apos;s Hospital</orgName>
								<address>
									<addrLine>30 Flemington Road</addrLine>
									<postCode>3052</postCode>
									<settlement>Parkville</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">HPV vaccination of immunocompromised hosts</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-06-03">03 June 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">C11D008032A4C767D44388318F3C74AC</idno>
					<idno type="DOI">10.1016/j.pvr.2017.06.002</idno>
					<note type="submission">Received 28 April 2017; Received in revised form 2 June 2017; Accepted 2 June 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:10+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>Human papillomavirus (HPV) Vaccination Immunocompromised hosts HPV related cancers HPV Guidelines</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent.</s><s>Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to national guidelines.</s><s>When delivered to immunocompromised populations, HPV vaccines should be given as a 3-dose regimen.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p><s>For the immunocompetent host, there are clear guidelines on the use of prophylactic human papillomavirus [HPV] vaccines (bivalent [2vHPV], quadrivalent [4vHPV] and nonavalent [9vHPV]) available from various international public health authorities, regulatory agencies and societies.</s><s>These include the World Health Organisation (WHO) <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>, European Medicines Agency (EMA) <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b3">4]</ref>, as well as numerous national advisory committees worldwide, such as the Food and Drug Administration (FDA), US Advisory Committee on Immunisation Practices (ACIP) <ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref> American Society of Clinical Oncology [ASCO], Australian Therapeutic Goods Administration (TGA), Australian Technical Advisory Group on Immunisation <ref type="bibr" target="#b10">[11]</ref>, National Advisory Committee on Immunisation (NACI) in Canada <ref type="bibr" target="#b11">[12]</ref>, and International Papillomavirus Society (IPVS) <ref type="bibr" target="#b12">[13]</ref>.</s><s>The currently licensed vaccines are viral-like-particles, which are subunit, non-replicating, and do not contain any infectious component.</s><s>There is good evidence that HPV 16 and 18 contribute globally to 70% of cervical cancers <ref type="bibr" target="#b13">[14]</ref>, 78% of HPV related vulvar cancer <ref type="bibr" target="#b14">[15]</ref>, 65% of vaginal <ref type="bibr" target="#b15">[16]</ref> and 90% of anal cancers in both sexes <ref type="bibr" target="#b16">[17]</ref>, as well as a geographically variable proportion of oropharyngeal cancers.</s><s>Hence, the expected reduction in disease is substantial for those vaccinated with the 2vHPV or 4vHPV vaccine when given prior to HPV infection.</s><s>Moreover, with the new 9vHPV vaccine, the proportion of the cancer burden that is potentially preventable in women rises an incremental amount to approximately 90% <ref type="bibr" target="#b17">[18,</ref><ref type="bibr" target="#b18">19]</ref>, 92% <ref type="bibr" target="#b14">[15]</ref>, 86% <ref type="bibr" target="#b15">[16]</ref> and 95% <ref type="bibr" target="#b16">[17]</ref>, respectively, for cervical, vulvar, vaginal and vulvar cancer.</s><s>These guidelines generally focus attention on vaccination of female preadolescents (target age is country-specific and dependent upon delivery strategy) from 9 to 14 years of age and prior to sexual debut, although some have included a catch-up period up to 26 years of age.</s><s>In some countries, there is a gender-neutral approach including boys.</s><s>Based on immunogenicity data, and following endorsement from the WHO in 2014, a two-dose regimen is now recommended in many countries for immunocompetent individuals aged under 15 years at receipt of the first vaccine dose, with a dose interval of at least 6 months.</s><s>Those who are 15 years or older at first dose, or those who are immunocompromised, require the standard three-dose vaccination schedule <ref type="bibr" target="#b0">[1]</ref>.</s></p><p><s>Guidelines for HPV vaccination of the immunocompromised host are provided in some countries by specialist immunisation advisory groups or societies <ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref>.</s><s>In many countries immunisation for these groups is recommended, regardless of age, but not nationally funded.</s><s>In this position statement, we outline the rationale for ensuring that clinicians, patients and policy makers explicitly consider the potential role of HPV vaccination in immunocompromised individuals.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Immunocompromised hosts</head><p><s>Immunocompromised hosts include those with infections affecting immune competency such as human immunodeficiency virus (HIV), and those on immunosuppressive and/or immunomodulatory treatment for autoimmune conditions (e.g.</s><s>multiple sclerosis, inflammatory bowel disease, systemic lupus erythematosus (SLE)), or for prevention of graft rejection among those who are post-transplantation.</s></p><p><s>It has been well documented that HIV-positive women, have an overall higher prevalence of HPV DNA two or threefold higher than HIV negative women <ref type="bibr" target="#b24">[25]</ref> (60-70%), have a higher prevalence of highrisk-HPV DNA (20-35%) <ref type="bibr" target="#b25">[26]</ref>, types that are known to cause cancer, more likely to have multiple HPV types present (35-50%) <ref type="bibr" target="#b24">[25]</ref>, higher HPV viral loads (45-60%) <ref type="bibr" target="#b24">[25]</ref> and persistent HR-HPV infections (45% vs 15%) <ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref>. Notably a lower CD4 count in female patients is strongly associated with cervical and anal high grade squamous intraepithelial lesions (HSIL).</s><s>There is also a greater risk of vulvar HSIL <ref type="bibr" target="#b29">[30]</ref>, a 10-fold greater risk of anal cancer <ref type="bibr" target="#b30">[31]</ref> and a three to five fold higher risk for cervical SIL, with invasive cervical cancer being an AIDS-defining illness <ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref>.</s><s>In addition for males and females who are HIV-positive there is a higher risk of HR-HPV anal infection, anal HSIL and anal cancer <ref type="bibr" target="#b36">[37,</ref><ref type="bibr" target="#b37">38]</ref>.</s><s>Although this association is presumably due to impaired ability to clear HPV and increased reactivation of latent infection <ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref><ref type="bibr" target="#b43">[44]</ref><ref type="bibr" target="#b44">[45]</ref>, other mechanisms may be involved that result in cellular immune dysfunction <ref type="bibr" target="#b45">[46,</ref><ref type="bibr" target="#b46">47]</ref>.</s></p><p><s>Those who are immunocompromised for reasons other than HIV infection are also at increased risk of HPV infection, HSIL and cancer compared with immunocompetent individuals <ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b39">40,</ref><ref type="bibr" target="#b42">43,</ref><ref type="bibr" target="#b44">45,</ref><ref type="bibr" target="#b47">[48]</ref><ref type="bibr" target="#b48">[49]</ref><ref type="bibr" target="#b49">[50]</ref><ref type="bibr" target="#b50">[51]</ref><ref type="bibr" target="#b51">[52]</ref><ref type="bibr" target="#b52">[53]</ref><ref type="bibr" target="#b53">[54]</ref>.</s><s>For example, prior to prophylactic vaccines being available, bone marrow transplantation patients had a higher rate of cervical HSIL than in the age-adjusted general population <ref type="bibr" target="#b47">[48]</ref>.</s><s>Moreover, it was recognised that allogeneic transplant recipients had a higher rate of cervical abnormalities than did patients receiving autologous transplants <ref type="bibr" target="#b47">[48,</ref><ref type="bibr" target="#b53">54]</ref>.</s><s>Higher rates of cervical abnormalities have also been found in studies of women with SLE, rheumatoid arthritis and inflammatory bowel disease when on immunosuppressant medications <ref type="bibr" target="#b42">[43,</ref><ref type="bibr" target="#b44">45]</ref>.</s></p><p><s>Individuals who are HIV positive remain at risk for acquiring new HPV infections which likely can be prevented by HPV vaccination.</s><s>This includes prevention of HR infections that can progress to HSIL.</s><s>It is to be noted that highly active antiretroviral therapy (HAART) has modest effect or no effect on HPV carriage, clearance or persistence <ref type="bibr" target="#b27">[28]</ref> , although recent reports suggest a decline in cervical HSIL <ref type="bibr" target="#b54">[55]</ref>.</s><s>Recent studies show that management guidelines for women on HAART with HIV viral suppression, can parallel guidelines for healthy women <ref type="bibr" target="#b55">[56]</ref>.</s><s>Moreover, immunosuppressed patients are also at a higher risk of HSIL due to low risk HPV types <ref type="bibr" target="#b56">[57]</ref><ref type="bibr" target="#b57">[58]</ref><ref type="bibr" target="#b58">[59]</ref>.</s><s>In those who are HIV-positive, as all immunosuppressed peoples, there is also greater risk of genital warts being recalcitrant to treatment <ref type="bibr" target="#b29">[30]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1.">A growing evidence base: HPV vaccine studies in immunocompromised people</head><p><s>The increased risk of HPV infection and associated diseases in immunocompromised men and women warrants a strong emphasis on vaccinating these individuals according to the relevant national guidelines.</s><s>Individuals who meet these guidelines may be vaccinated while immunocompromised or ideally, prior to the development of immunocompromised status.</s></p><p><s>The 4vHPV vaccine has been administered to HIV-positive children 7-12 years of age with seroconversion rates greater than 96% <ref type="bibr" target="#b59">[60]</ref>.</s><s>Antibody titres for HPV 6/11/16/18, were 30-50% lower compared with historical age-matched controls, but higher than natural infections and in the range where clinical efficacy is seen in adults <ref type="bibr" target="#b59">[60]</ref>.</s><s>Studies in vertically-acquired HIV-positive adolescents adult men and women show high rates of seroconversion (95-100%), with no adverse effects on CD4 or plasma HIV RNA levels <ref type="bibr" target="#b60">[61]</ref><ref type="bibr" target="#b61">[62]</ref><ref type="bibr" target="#b62">[63]</ref><ref type="bibr" target="#b63">[64]</ref><ref type="bibr" target="#b64">[65]</ref><ref type="bibr" target="#b65">[66]</ref><ref type="bibr" target="#b66">[67]</ref><ref type="bibr" target="#b67">[68]</ref>.</s><s>We currently await efficacy data, although 4vHPV vaccine will likely benefit immunocompromised men and women when vaccinated in the recommended age range, despite the lower titres seen in this population.</s></p><p><s>For the 2vHPV vaccine, similar studies in HIV-positive women demonstrated high seroconversion rates, and sustained positivity for anti-HPV 16 and 18 over 12 months.</s><s>Although lower antibody titres were seen than in HIV-negative controls, the titres remained well above levels seen following natural infection <ref type="bibr" target="#b68">[69]</ref>.</s><s>As with the 4vHPV vaccine, the 2vHPV vaccine showed no adverse effect on CD4 count over time, nor effect on HIV viral load over time: however these studies have been performed in largely HIV positive subjects enrolled with reasonably high CD4 counts.</s></p><p><s>Vaccination in other immunocompromised groups, including patients with solid organ transplants and autoimmune disorders have demonstrated lower titres of antibodies in these patients compared with controls.</s><s>These included patients with juvenile idiopathic arthritis, SLE, juvenile dermatomyositis, and kidney and lung transplant <ref type="bibr" target="#b70">[70]</ref><ref type="bibr" target="#b71">[71]</ref><ref type="bibr" target="#b72">[72]</ref><ref type="bibr" target="#b73">[73]</ref>.</s><s>One study noted that titres appeared to differ by type of immunosuppressive drug treatment, with patients on mycophenolate producing lower HPV antibody titres than patients on other drugs <ref type="bibr" target="#b73">[73]</ref>.</s><s>Another study indicated that lung transplant patients had much lower antibodies than other solid organ transplant recipients <ref type="bibr" target="#b70">[70]</ref>.</s><s>However, these studies all showed that the vaccines were safe and consistently found that HPV vaccination was not associated with significant adverse effects and importantly, the clinical course of these diseases were also not affected <ref type="bibr" target="#b73">[73]</ref><ref type="bibr" target="#b74">[74]</ref><ref type="bibr" target="#b75">[75]</ref>.</s></p><p><s>Given that the recommendation for two dose schedules of HPV vaccines is currently based upon bridging data, showing equivalent immunogenicity in immunocompetent young adolescents as three doses in older persons in whom efficacy has been assessed, there is no current evidence to support equivalence in immunocompromised individuals.</s><s>Consequently, the recommendations for those who are immunosuppressed or HIV-positive should be for 3 doses, within the recommended age guidelines and as early as possible prior to the onset of immunocompromise.</s><s>Continued research in this group of vaccine recipients is necessary.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Screening remains important</head><p><s>Currently screening remains a critical component of cervical cancer prevention for all women, regardless of HPV vaccination status.</s><s>Because of their increased risk of cervical HSIL and cervical cancer, risk of disease due to non-vaccine HPV types and the lack of efficacy studies post-vaccination, secondary prevention through screening remains critical for immunocompromised women, regardless of HPV vaccination status.</s><s>Most countries recommend more frequent screening for these women than for the general population on the basis of their higher risk <ref type="bibr" target="#b76">[76]</ref><ref type="bibr" target="#b77">[77]</ref><ref type="bibr" target="#b78">[78]</ref><ref type="bibr" target="#b79">[79]</ref>.</s><s>Studies are in progress to determine whether screening for, and treatment of, anal HSIL is of value in preventing anal cancer in at-risk populations <ref type="bibr" target="#b80">[80]</ref><ref type="bibr" target="#b81">[81]</ref><ref type="bibr" target="#b82">[82]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Key points IPVS statement on HPV vaccination and immunocompromised hosts</head><p><s>• Immunocompromised people are at increased risk of HPV-related disease, compared with immunocompetent people.</s></p><p><s>HPV vaccination is safe in immunocompromised people (e.g., HIV-positive [+] individuals, transplant recipients).</s></p><p><s>• Current vaccines are simple, non-replicating subunit vaccines and hence, not infectious.</s></p><p><s>• Given current knowledge, HPV vaccines will likely benefit immunocompromised men and women, especially when vaccinated in the recommended age range.</s></p><p><s>• It is ideal to vaccinate everyone according to national guidelines, before people become immunocompromised.</s></p><p><s>• For those who are immunocompromised at the time of vaccination, 3 doses are currently recommended.</s></p><p><s>• Antibody titres in response to vaccination are often lower than those in immunocompetent people, but the clinical relevance of this is yet unknown.</s><s>Efficacy data following vaccination in immunocompromised people are very limited to date.</s></p><p><s>• Vaccines that have broad coverage or cross-coverage should be encouraged for HIV (+) men and women given growing evidence that the distribution of HPV types in cancers may be broader than that seen in the immunocompetent population.</s></p><p><s>• Cervical cancer screening remains an important public health complement to HPV vaccination for the prevention of cervical cancer.</s></p></div>		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">World Health Organisation Meeting of the Strategic Advisory Group of Experts on Immunisation April 2014 -Conclusions and Recommendations</title>
	</analytic>
	<monogr>
		<title level="j">Weekly Epidemiological Record</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">89</biblScope>
			<biblScope unit="page" from="221" to="236" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Human Papillomavirus Vaccines: WHO Position Paper</title>
	</analytic>
	<monogr>
		<title level="j">Weekly Epidemiological Record</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="issue">43</biblScope>
			<biblScope unit="page" from="456" to="492" />
			<date type="published" when="2014-10">October 2014. 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title/>
		<ptr target="//www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/003852/WC500189114.pdf〉" />
	</analytic>
	<monogr>
		<title level="j">EPAR Summary for the Public Gardasil</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">EMA/789820/2013 Committee for Medicinal Products for Human Use</title>
		<ptr target="〈http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000721/WC500160885.pdf〉" />
	</analytic>
	<monogr>
		<title level="j">CHMP) Assessment Report Cervarix</title>
		<imprint>
			<date type="published" when="2013-11-21">21 November 2013</date>
		</imprint>
	</monogr>
	<note>European Medicines Agency</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)</title>
	</analytic>
	<monogr>
		<title level="j">Centers for Disease Control Prevention</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page">626</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>MMWR Morb. Mortal. Wkly. Rep.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<author>
			<persName><surname>Le Markowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dunne</surname></persName>
		</author>
		<author>
			<persName><surname>Saraiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hw Lawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Chesson</surname></persName>
		</author>
		<author>
			<persName><surname>Unger</surname></persName>
		</author>
		<title level="m">Centers for Disease C, Prevention, Advisory Committee on Immunization P: Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity &amp; Mortality Weekly Report Recommendations &amp; Reports</title>
				<imprint>
			<date type="published" when="2007">2007</date>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="1" to="24" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Markowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Dunne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Saraiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Chesson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Robinette</forename><surname>Curtis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Bocchini</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Unger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Human papillomavirus vaccination recommendations of the Advisory Committee on Immunisation Practices (ACIP)</title>
				<imprint>
			<date type="published" when="2014">2014</date>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="1" to="30" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
	</analytic>
	<monogr>
		<title level="m">Centers for Disease Control and Prevention Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males -Advisory Committee on Immunisation Practices (ACIP)</title>
				<imprint>
			<date type="published" when="2011">2011</date>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="1705" to="1708" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Control CfD, prevention: use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices</title>
		<author>
			<persName><forename type="first">E</forename><surname>Petrosky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Bocchini</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hariri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Chesson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Curtis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Saraiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Unger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Markowitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">MMWR Morb. Mortal. Wkly. Rep</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="300" to="304" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<title level="m" type="main">ACIP Recommends Two-dose Regimen for HPV Vaccines</title>
		<ptr target="〈http://www.aafp.org/news/health-of-the-public/20161026acipoctmtg.html〉" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<ptr target="〈http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/handbook10-home〉" />
		<title level="m">The Australian Immunisation Handbook</title>
				<imprint/>
	</monogr>
	<note>10th edition</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Update on the recommended Human Papillomavirus (HPV) vaccine immunisation schedule</title>
		<ptr target="〈http://www.phac-aspc.gc.ca/naci-ccni/acs-dcc/2015/hpv-vph_0215-eng.php〉" />
	</analytic>
	<monogr>
		<title level="m">An Advisory Committee Statement (ACS) National Advisory Committee on Immunisation (NACI)</title>
				<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Garland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stanley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Brotherton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Moscicki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bhatla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Kaufmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sankaranarayanan</surname></persName>
		</author>
		<author>
			<persName><surname>Pjobo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">IPVS policy statement on safety of HPV vaccines</title>
				<imprint>
			<date type="published" when="2016">2016</date>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="9" to="10" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<author>
			<persName><forename type="first">D</forename><surname>Forman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Martel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Lacey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Soerjomataram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lortet-Tieulent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bruni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vignat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ferlay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Plummer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Global burden of human papillomavirus and related diseases</title>
				<imprint>
			<date type="published" when="2012">2012</date>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="F12" to="F23" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva</title>
		<author>
			<persName><forename type="first">S</forename><surname>De Sanjosé</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Alemany</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ordi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tous</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alejo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Bigby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Joura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Maldonado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Laco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">G</forename><surname>Bravo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Cancer</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="3450" to="3461" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples</title>
		<author>
			<persName><forename type="first">L</forename><surname>Alemany</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Saunier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tinoco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Quirós</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Alvarado-Cabrero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alejo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Joura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Maldonado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Klaustermeier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Salmerón</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Cancer</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="2846" to="2854" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide</title>
		<author>
			<persName><forename type="first">L</forename><surname>Alemany</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Saunier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Alvarado-Cabrero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Quirós</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Salmeron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Pirog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Guimerà</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hernandez-Suarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Felix</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Cancer</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="98" to="107" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Joura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Giuliano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O.-E</forename><surname>Iversen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bouchard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mehlsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Moreira</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ngan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lazcano-Ponce</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="711" to="723" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease</title>
		<author>
			<persName><forename type="first">B</forename><surname>Serrano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Alemany</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tous</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bruni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Clifford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Weiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">X</forename><surname>Bosch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sanjosé</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect. Agents Cancer</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">1</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<monogr>
		<title level="m" type="main">Human Papillomavirus (HPV) ACIP Vaccine Recommendations</title>
		<ptr target="〈https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/hpv.html〉" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<title level="m" type="main">Human Papillomavirus (HPV): The Green Book, Chapter 18a</title>
		<ptr target="〈https://www.gov.uk/government/publications/human-papillomavirus-hpv-the-green-book-chapter" />
		<imprint/>
	</monogr>
	<note>18a〉</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">IDSA clinical practice guideline for vaccination of the immunocompromised host</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Rubin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Levin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ljungman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Avery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tomblyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bousvaros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dhanireddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Keyserling</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Infect. Dis</title>
		<imprint>
			<date type="published" when="2013">2013. 2013</date>
		</imprint>
	</monogr>
	<note>cit684</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Human papillomavirus vaccination in survivors of childhood cancer</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Klosky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Gamble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Spunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Randolph</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Hudson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="5627" to="5636" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title level="m" type="main">Cancer Immunisation Guideline: Chemotherapy and Post Hematopoietic Stem Cell Transplant</title>
		<ptr target="〈http://www.mvec.vic.edu.au/immunisation-references/cancer-immunisation-guideline-chemotherapy-and-post-hematopoietic-stem-cell-transplant/〉" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Group HERSCharacterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Jamieson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Duerr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Burk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Paramsothy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schuman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cu-Uvin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Obstet. Gynecol</title>
		<imprint>
			<biblScope unit="volume">186</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="21" to="27" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Palefsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Minkoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Kalish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Levine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Sacks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Melnick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Miotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Burk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Natl. Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="226" to="236" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women</title>
		<author>
			<persName><forename type="first">L</forename><surname>Ahdieh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Burk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cu-Uvin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schuman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Duerr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Safaeian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Astemborski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Daniel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Infect. Dis</title>
		<imprint>
			<biblScope unit="volume">184</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="682" to="690" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents</title>
		<author>
			<persName><forename type="first">S</forename><surname>Shrestha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Sudenga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Bachmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Kempf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Infect. Dis</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">1</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load</title>
		<author>
			<persName><forename type="first">I</forename><surname>Heard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-M</forename><surname>Tassie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Schmitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mandelbrot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Kazatchkine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Orth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obstet. Gynecol</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="403" to="409" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Conley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">V</forename><surname>Ellerbrock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Bush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Chiasson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sawo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Wright</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">359</biblScope>
			<biblScope unit="issue">9301</biblScope>
			<biblScope unit="page" from="108" to="113" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Group ACMRSHuman papillomavirusassociated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome</title>
		<author>
			<persName><forename type="first">M</forename><surname>Frisch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Biggar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Goedert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Natl. Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="1500" to="1510" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIVseronegative women</title>
		<author>
			<persName><forename type="first">P</forename><surname>Schuman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Ohmit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Duerr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cu-Uvin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Jamieson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">V</forename><surname>Shah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Infect. Dis</title>
		<imprint>
			<biblScope unit="volume">188</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="128" to="136" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus</title>
		<author>
			<persName><forename type="first">A</forename><surname>Duerr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kieke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Warren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Burk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Peipert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schuman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Klein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Obstet. Gynecol</title>
		<imprint>
			<biblScope unit="volume">184</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="584" to="590" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Long-term incidence of cervical cancer in women with human immunodeficiency virus</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Massad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Seaberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Watts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Minkoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Levine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Henry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Colie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Darragh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Hessol</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="524" to="530" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women</title>
		<author>
			<persName><forename type="first">C</forename><surname>Six</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Heard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bergeron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Orth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-D</forename><surname>Poveda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zagury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cesbron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Crenn-Hébert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pradinaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sobesky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1047" to="1056" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">V</forename><surname>Ellerbrock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Chiasson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Van Devanter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X.-W</forename><surname>Sun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obstet. Gynecol</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="591" to="597" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIVpositive and HIV-negative homosexual men</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Palefsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Holly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Hogeboom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Ralston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Dacosta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Botts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Berry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Jay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Darragh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Acquir. Immune Defic. Syndr</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="314" to="319" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Machalek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Poynten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Fairley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Farnsworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Garland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Hillman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Petoumenos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Tabrizi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Oncol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="487" to="500" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">HPV carcinomas in immunocompromised patients</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Reusser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Downing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Guidry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Tyring</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Med</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="260" to="281" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">A cross-sectional analysis of lower genital tract intraepithelial neoplasia in immune-compromised women with an abnormal Pap</title>
		<author>
			<persName><forename type="first">W</forename><surname>Likes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Santoso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch. Gynecol. Obstet</title>
		<imprint>
			<biblScope unit="volume">287</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="743" to="747" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">HPV infection and vaccination in Systemic Lupus Erythematosus patients: what we really should know</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H R</forename><surname>Grein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Groot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Lacerda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wulffraat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pileggi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr. Rheumatol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">12</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: a meta-analysis of the literature</title>
		<author>
			<persName><forename type="first">E</forename><surname>Zard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Arnaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mathian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Chakhtoura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Touraine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Heard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Amoura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Autoimmun. Rev</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="730" to="735" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">IBD: incidence of HSV and HPV with azathioprine</title>
		<author>
			<persName><forename type="first">M</forename><surname>Cottone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Renna</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Gastroenterol. Hepatol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="444" to="445" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<monogr>
		<title level="m" type="main">Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Feldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Feldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Solomon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Kim</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2016">2016. 0961203316672928</date>
			<pubPlace>Lupus</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a populationbased cohort study</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Glynn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Giovannucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hernández-Díaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Feldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Karlson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schneeweiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Solomon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Rheum. Dis</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1360" to="1367" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Associations of anogenital low-risk human papillomavirus infection with cancer and acquisition of HIV</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Bennetts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Giuliano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Palefsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Steben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Weiss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sex. Transm. Dis</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="541" to="544" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Smith-Mccune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shiboski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Z</forename><surname>Chirenje</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Magure</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tuveson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Costa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A.-B</forename><surname>Moscicki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Palefsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Makunike-Mutasa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">e10094</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Post-Transplant Complications-Abnormal cervical cytology in bone marrow transplant recipients</title>
		<author>
			<persName><forename type="first">J</forename><surname>Sasadeusz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Szer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schwarer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Grigg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone Marrow Transplant</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="393" to="398" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Prevalence of HPV DNA in cervical specimens in women with renal transplants: a comparison with dialysis-dependent patients and patients with renal impairment</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Fairley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Tabrizi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcneil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Atkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Thomson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Allan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Woodburn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nephrol. Dial. Transplant</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="416" to="420" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Prospective study of HPV DNA in cervical specimens from women with renal transplants</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Fairley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Tabrizi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Atkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Garland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nephrol. Dial. Transplant</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1520" to="1521" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts</title>
		<author>
			<persName><forename type="first">M</forename><surname>Alloub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Barr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mclaren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bunney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Smart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br. Med. J</title>
		<imprint>
			<biblScope unit="volume">298</biblScope>
			<biblScope unit="issue">6667</biblScope>
			<biblScope unit="page" from="153" to="156" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Human papillomavirus and lower genital neoplasia in renal transplant patients</title>
		<author>
			<persName><forename type="first">R</forename><surname>Halpert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Fruchter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sedlis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Butt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Boyce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sillman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obstet. Gynecol</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="251" to="258" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients</title>
		<author>
			<persName><forename type="first">O</forename><surname>Ogunbiyi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Scholefield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Raftery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Duffy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sharp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rogers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br. J. Surg</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="365" to="367" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation; implications for screening and HPV vaccination</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Savani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Stratton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shenoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kozanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Barrett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol. Blood Marrow Transplant</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1072" to="1075" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: a nested casecontrol study in the Swiss HIV cohort study</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Clifford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Franceschi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Keiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schöni-Affolter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dehler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Levi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mousavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bouchardy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wolfensberger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Cancer</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1732" to="1740" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Incidence of cervical precancers among HIVseropositive women</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Massad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Darragh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Minkoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Colie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sanchez-Keeland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Strickler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Obstet. Gynecol</title>
		<imprint>
			<biblScope unit="volume">212</biblScope>
			<biblScope unit="issue">5</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>606. e601-606. e608)</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Human papillomavirus infection in solid organ transplant recipients</title>
		<author>
			<persName><forename type="first">E</forename><surname>Kwak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Julian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Transplant</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">s4</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Human papillomavirus-related genital disease in the immunocompromised host</title>
		<author>
			<persName><surname>Rh Gormley</surname></persName>
		</author>
		<author>
			<persName><surname>Kovarik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Am. Acad. Dermatol</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="e861" to="867" />
		</imprint>
	</monogr>
	<note>e814</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Anal and perianal squamous carcinomas and high-grade intraepithelial lesions exclusively associated with &quot;low-risk&quot; HPV genotypes 6 and 11</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Cornall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Garland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Hillman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Grulich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Tabrizi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Cancer</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2253" to="2258" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIVinfected children 7 to 12 years old</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Levin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A.-B</forename><surname>Moscicki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L.-Y</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fenton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Iii</forename></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Read</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Handelsman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nowak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Sattler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Saah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Acquir. Immune Defic. Syndr</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">197</biblScope>
			<date type="published" when="1999">1999. 2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">HPV4, Vaccine immunogenicity/effectiveness in Perinatally HIV-Infected (PHIV) youth</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Moscicki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Karalius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jacobson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Purswani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Seage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proceedings of the 31st International Papillomavirus Conference &amp; Clinical and Public Health Workshops in Cape Town, South Africa, Abstract No. 317a</title>
				<meeting>the 31st International Papillomavirus Conference &amp; Clinical and Public Health Workshops in Cape Town, South Africa, Abstract No. 317a</meeting>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men</title>
		<author>
			<persName><forename type="first">T</forename><surname>Wilkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Lensing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Stier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Goldstone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Berry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Jay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Aboulafia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Cohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Einstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Infect. Dis</title>
		<imprint>
			<biblScope unit="volume">202</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1246" to="1253" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Vaccination against oncogenic human papillomavirus infection in HIV-infected populations: review of current status and future perspectives</title>
		<author>
			<persName><forename type="first">L</forename><surname>Toft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tolstrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Storgaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Østergaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">S</forename><surname>Søgaard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sex. Health</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="511" to="523" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Human papilloma virus vaccination induces strong human papilloma virus specific cell-mediated immune responses in HIV-infected adolescents and young adults</title>
		<author>
			<persName><forename type="first">V</forename><surname>Rainone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Giacomet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Penagini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Fabiano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Calascibetta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mameli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pisanelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Zuccotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Clerici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Trabattoni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="739" to="743" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Money</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Moses</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Blitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Vandriel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Lipsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Walmsley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Loutfy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Trottier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Smaill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Yudin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine</title>
				<imprint>
			<date type="published" when="2016">2016</date>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="4799" to="4806" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Kojic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Cespedes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Umbleja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Godfrey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Firnhaber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Grinsztejn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Palefsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Webster-Cyriaque</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Infect. Dis</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="127" to="135" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Immunogenicity and safety of the human papillomavirus-6,-11,-16,-18 vaccine in HIV-infected young women</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Kapogiannis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rudy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gonin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Worrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Squires</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Infect. Dis</title>
		<imprint>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>cit319</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Human Papillomavirus neutralizing and cross-reactive antibodies induced in HIV-positive subjects after vaccination with quadrivalent and bivalent HPV vaccines</title>
		<author>
			<persName><forename type="first">H</forename><surname>Faust</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Toft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sehr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Müller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bonde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Forslund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Østergaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tolstrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dillner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="1559" to="1565" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">L</forename><surname>Denny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hendricks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hezareh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dobbelaere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Durand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hervé</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Descamps</surname></persName>
		</author>
		<idno>HPV-16/18</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
	</analytic>
	<monogr>
		<title level="m">AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study</title>
				<imprint>
			<date type="published" when="2013">2013</date>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="5745" to="5753" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Unger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Panicker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Medvedev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Humar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Transplant</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2411" to="2417" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Immunogenicity, safety and tolerability of a bivalent human papillomavirus vaccine in adolescents with juvenile idiopathic arthritis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Esposito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Corona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Barzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cuoco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Squarzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Marcati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Torcoletti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gambino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Palù</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Principi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Rev. Vaccin</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1387" to="1393" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Heijstek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Scherpenisse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Groot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tacke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Schepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A.-M</forename><surname>Buisman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Berbers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Van Der Klis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Wulffraat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Rheum. Dis</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1500" to="1507" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Mok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Y</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Fong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>To</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Rheum. Dis</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="659" to="664" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study</title>
		<author>
			<persName><forename type="first">O</forename><surname>Grönlund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Herweijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sundström</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Arnheim-Dahlström</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Intern. Med</title>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="618" to="626" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: six years of casereferent surveillance</title>
		<author>
			<persName><forename type="first">L</forename><surname>Grimaldi-Bensouda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rossignol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Koné-Paut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Krivitzky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lebrun-Frenay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Clet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Brassat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Papeix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nicolino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P.-Y</forename><surname>Benhamou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Autoimmun</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="84" to="90" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<monogr>
		<title level="m" type="main">Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline. 〈www.asco.org/rs-cervical-cancer-secondary-prev-guideline〉</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<monogr>
		<ptr target="〈https://www.gov.uk/government/collections/cervical-screening-professional-guidance〉" />
		<title level="m">Cervical Screening: Professional Guidance</title>
				<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<monogr>
		<title level="m" type="main">NHMRC Screening to Prevent Cervical Cancer: Guidelines for the Management of Asymptomatic Women with Screen Detected Abnormalities</title>
		<ptr target="〈www.nhmrc.gov.au/publications〉" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<monogr>
		<title level="m" type="main">European Guidelines for Quality Assurance in Cervical Cancer Screening</title>
		<ptr target="〈http://screening.iarc.fr/doc/ND7007117ENC_002.pdf〉" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">A composite cytologyhistology endpoint allows a more accurate estimate of anal high grade squamous intraepithelial lesion prevalence</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Machalek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Poynten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Hillman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Templeton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Law</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Tabrizi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Garland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Farnsworth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol. Prev. Biomark</title>
		<imprint>
			<biblScope unit="volume">1106</biblScope>
			<date type="published" when="2015">2016. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">The Study of the Prevention of Anal Cancer (SPANC): design and methods of a three-year prospective cohort study</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Machalek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Grulich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Hillman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Templeton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Tabrizi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Garland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Prestage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mccaffery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Howard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Public Health</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="946" to="946" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<monogr>
		<title level="m" type="main">ANCHOR: Anal Cancer/HSIL Outcomes Research Study</title>
		<ptr target="〈https://jcto.weill.cornell.edu/open_clinical_trials/anchor-anal-cancerhsil-outcomes-research-study〉" />
		<imprint/>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
